Evidence map›Paper›PMID 41858375›Full record

ArticleOncology letters2026

RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9.

Jun Luo, Guang Li, Mei Ye, Xiaoqing Xu, Mengwen Qi, Jian Huang, Kong Shan, Lili Qu, Hengchuan Shi

Abstract read
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jun LuoReproductive Testing Quality Control Department of Central Laboratory, Jiangsu Health Vocational College, Nanjing, Jiangsu 211800, P.R. China.
Guang LiDepartment of Laboratory Medicine, Geriatric Hospital of Nanjing Medical University: Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu 212008, P.R. China.
Mei YeDepartment of Gynecology, Nanjing Jiangning District Women and Children's Healthcare Hospital, Nanjing, P.R. China.
Xiaoqing XuReproductive Testing Quality Control Department of Central Laboratory, Jiangsu Health Vocational College, Nanjing, Jiangsu 211800, P.R. China.
Mengwen QiReproductive Testing Quality Control Department of Central Laboratory, Jiangsu Health Vocational College, Nanjing, Jiangsu 211800, P.R. China.
Jian HuangKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200241, P.R. China.
Kong ShanDepartment of Laboratory Medicine, Geriatric Hospital of Nanjing Medical University: Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu 212008, P.R. China.
Lili QuReproductive Testing Quality Control Department of Central Laboratory, Jiangsu Health Vocational College, Nanjing, Jiangsu 211800, P.R. China.
Hengchuan ShiDepartment of Laboratory Medicine, Geriatric Hospital of Nanjing Medical University: Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu 212008, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasculogenic mimicry (VM), which creates an endothelium-independent tumor microcirculation, is associated with tumor metastasis and drug resistance, which are key challenges in the clinical treatment of cervical cancer (CC). The malignant progression of a variety of tumors is supported by the 5-methylcytidine (m

Indexed as

cervical cancerMMP-9NSUN2vasculogenic mimicry

Identifiers

PMID41858375
PMCPMC12997395

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.